An altered fibronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of FAK and ERK

Apoptosis

Volumn 12, Issue 12, 2007, Pages 2221-2231

  Kamarajan, Pachiyappan ^a   Kapila, Yvonne L ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

Author keywords

Anoikis; Fibronectin fragments; Focal adhesion kinase; Integrins

Indexed keywords

ALPHA5 INTEGRIN; CASPASE 3; CASPASE 8; FIBRONECTIN; FOCAL ADHESION KINASE; HEPARIN BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANOIKIS; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE;

ANOIKIS; CARCINOMA, SQUAMOUS CELL; CASPASE 3; CELL LINE, TUMOR; DOWN-REGULATION; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBRONECTINS; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; INTEGRIN ALPHAV; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION;

EID: 35948970578     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-007-0138-9     Document Type: Article

References (75)

1. Gilcrease MZ (2007) Integrin signaling in epithelial cells. Cancer Lett 247:1-25
2. Pytela R, Pierschbacher MD, Ruoslahti E (1985) Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor. Cell 40:191-198
3. Busk M, Pytela R, Sheppard D (1992) Characterization of the integrin alpha v beta 6 as a fibronectin-binding protein. J Biol Chem 267:5790-5796
4. Charo IF, Nannizzi L, Smith JW, Cheresh DA (1990) The vitronectin receptor alpha v beta 3 binds fibronectin and acts in concert with alpha 5 beta 1 in promoting cellular attachment and spreading on fibronectin. J Cell Biol 111:2795-2800
5. Frisch SM, Ruoslahti E (1997) Integrins and anoikis. Curr Opin Cell Biol 9:701-706
6. Mould AP, Komoriya A, Yamada KM, Humphries MJ (1991) The CS5 peptide is a second site in the IIICS region of fibronectin recognized by the integrin alpha 4 beta 1. Inhibition of alpha 4 beta 1 function by RGD peptide homologues. J Biol Chem 266:3579-3585
7. Mould AP, Humphries MJ (1991) Identification of a novel recognition sequence for the integrin alpha 4 beta 1 in the COOH-terminal heparin-binding domain of fibronectin. EMBO J 10:4089-4095
8. Mitra SK, Hanson DA, Schlaepfer DD (2005) Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6:56-68
9. Sieg DJ, Hauck CR, Ilic D et al (2000) FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2:249-256
10. Schaller MD, Otey CA, Hildebrand JD, Parsons JT (1995) Focal adhesion kinase and paxillin bind to peptides mimicking beta integrin cytoplasmic domains. J Cell Biol 130:1181-1187
11. Guan JL, Shalloway D (1992) Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation. Nature 358:690-692
12. Huynh QN, Wang S, Tafolla E, Gansky SA, Kapila S, Armitage GC, Kapila YL (2002) Specific fibronectin fragments as markers of periodontal disease status. J Periodontol 73:1101-1110
13. Ffrench-Constant C, Van de Water L, Dvorak HF, Hynes RO (1989) Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol 109:903-914
14. Trefzer U, Hofmann M, Reinke S, Guo YJ, Audring H, Spagnoli G, Sterry W (2006) Concordant loss of melanoma differentiation antigens in synchronous and asynchronous melanoma metastases: implications for immunotherapy. Melanoma Res 16:137-145
15. Frisch SM, Francis H (1994) Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124:6619-6626
16. Wahl SM, Allen JB, Hines KL et al (1994) Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment. J Clin Invest 94:655-662
17. Natal C, Oses-Prieto JA, Pelacho B et al (2006) Regulation of apoptosis by peptides of fibronectin in human monocytes. Apoptosis 11:209-219
18. Dai R, Iwama A, Wang S, Kapila YL (2005) Disease-associated fibronectin matrix fragments trigger anoikis of human primary ligament cells: p53 and c-myc are suppressed. Apoptosis 10:503-512
19. Streuli CH, Gilmore AP (1999) Adhesion-mediated signaling in the regulation of mammary epithelial cell survival. J Mammary Gland Biol Neoplasia 4:183-191
20. Shanmugathasan M, Jothy S (2000) Apoptosis, anoikis and their relevance to the pathobiology of colon cancer. Pathol Int 50:273-279
21. Diaz-Montero CM, McIntyre BW (2003) PI3-K/Akt-mediated anoikis resistance of human osteosarcoma cells requires Src activation. Eur J Cancer 39:2395-2402
22. Wei L, Yang Y, Yu Q (2001) Tyrosine kinase-dependent, phosphatidylinositol 3′-kinase, and mitogen-activated protein kinase-independent signaling pathways prevent lung adenocarcinoma cells from anoikis. Cancer Res 61:2439-2444
23. Thomas GJ, Jones J, Speight PM (1997) Integrins and oral cancer. Oral Oncol 33:381-388
24. Silverman S Jr (2001) Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc 132:7S-11S
25. Xue H, Atakilit A, Zhu W, Li X, Ramos DM, Pytela R (2001) Role of the alpha(v)beta6 integrin in human oral squamous cell carcinoma growth in vivo and in vitro. Biochem Biophys Res Commun 288:610-618
26. Koivisto L, Grenman R, Heino J, Larjava H (2000) Integrins alpha5beta1, alphavbeta1, and alphavbeta6 collaborate in squamous carcinoma cell spreading and migration on fibronectin. Exp Cell Res 255:10-17
27. Thomas GJ, Hart IR, Speight PM, Marshall JF (2002) Binding of TGF-beta1 latency-associated peptide (LAP) to alpha(v) beta6 integrin modulates behaviour of squamous carcinoma cells. Br J Cancer 87:859-867
28. Ylipalosaari M, Thomas GJ, Nystrom M et al (2005) Alpha v beta 6 integrin down-regulates the MMP-13 expression in oral squamous cell carcinoma cells. Exp Cell Res 309:273-283
29. Vacca A, Ria R, Presta M et al (2001) Alpha(v)beta(3) integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells. Exp Hematol 29:993-1003
30. Mitjans F, Sander D, Adan J et al (1995) An anti-alpha v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice. J Cell Sci 108:2825-2838
31. Zhang Z, Vuori K, Reed JC, Ruoslahti E (1995) The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci USA 92:6161-6165
32. O'Brien V, Frisch SM, Juliano RL (1996) Expression of the integrin alpha 5 subunit in HT29 colon carcinoma cells suppresses apoptosis triggered by serum deprivation. Exp Cell Res 224:208-213
33. Zhang Y, Lu H, Dazin P, Kapila Y (2004) Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and integrin alphav mediate survival signals through focal adhesion kinase. J Biol Chem 279:48342-48349
34. Kapila YL, Niu J, Johnson PW (1997) The high affinity heparin-binding domain and the V region of fibronectin mediate invasion of human oral squamous cell carcinoma cells in vitro. J Biol Chem 272:18932-18938
35. Akiyama SK, Olden K, Yamada KM (1995) Fibronectin and integrins in invasion and metastasis. Cancer Met Rev 14:173-189
36. Yokota T, Oritani K, Mitsui H et al (1998) Growth-supporting activities of fibronectin on hematopoietic stem/progenitor cells in vitro and in vivo: structural requirement for fibronectin activities of CS1 and cell-binding domains. Blood 91:3263-3272
37. Kapila YL, Wang S, Dazin P, Tafolla E, Mass MJ (2002) The heparin-binding domain and V region of fibronectin regulate apoptosis by suppression of p53 and c-myc in human primary cells. J Biol Chem 277:8482-8491
38. Clark RA, An JQ, Greiling D, Khan A, Schwarzbauer JE (2003) Fibroblast migration on fibronectin requires three distinct functional domains. J Invest Dermatol 121:695-705
39. Peterson JA, Sheibani N, David G, Garcia-Pardo A, Peters DM (2005) Heparin II domain of fibronectin uses alpha4beta1 integrin to control focal adhesion and stress fiber formation, independent of syndecan-4. J Biol Chem 280:6915-6922
40. Owens LV, Xu L, Craven RJ et al (1995) Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res 55:2752-2755
41. Carey TE (1994) Head and neck tumor lines. In: Hay R, Gazdar A, Park J-G (eds) Atlas of human tumor cell lines. Academic Press Inc., Harcourt Brace Jovanovich Publishers, Orlando, pp 79-120
42. Kapila YL, Wang S, Johnson PW (1999) Mutations in the heparin binding domain of fibronectin in cooperation with the V region induce decreases in pp125(FAK) levels plus proteoglycan-mediated apoptosis via caspases. J Biol Chem 274:30906-30913
43. Barkalow FJ, Schwarzbauer JE (1991) Localization of the major heparin-binding site in fibronectin. J Biol Chem 266:7812-7818
44. Hamel W, Dazin P, Israel M (1996) Adaptation of a simple flow cytometric assay to identify different stages during apoptosis. Cytometry 25:173-181
45. Lallier T, Bronner-Fraser M (1993) Inhibition of neural crest cell attachment by integrin antisense oligonucleotides. Science 259:692-695
46. Townsend PA, Villanova I, Uhlmann E (2000) An antisense oligonucleotide targeting the alphaV integrin gene inhibits adhesion and induces apoptosis in breast cancer cells. Eur J Cancer 36:397-409
47. Akhtar S, Kole R, Juliano RL (1991) Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera. Life Sci 49:1793-1801
48. Zhang Y, Lu H, Dazing P, Kapila Y (2004) Functional differences between integrin alpha4 and integrins alpha5/alphav in modulating the motility of human oral squamous carcinoma cells in response to the V region and heparin-binding domain of fibronectin. Exp Cell Res 295:48-58
49. 2+/calmodulin-dependent protein kinase IV. J Cell Biochem 95:1214-1223
50. Giancotti FG, Ruoslahti E (1999) Integrin signaling. Science 285:1028-1032
51. Micheloni A, De Luca N, Tadini G, Zambruno G, D'Alessio M (2004) Intracellular degradation of beta4 integrin in lethal junctional epidermolysis bullosa with pyloric atresia. Br J Dermatol 151:796-802
52. Parsons JT (2003) Focal adhesion kinase: the first ten years. J Cell Sci 116:1409-1416
53. Schaller MD (2004) FAK and paxillin: regulators of N-cadherin adhesion and inhibitors of cell migration? J Cell Biol 166:157-159
54. Kapila YL, Lancero H, Johnson PW (1998) Specific fibronectin fragments as markers of periodontal disease status. J Periodontal 69:1008-1019
55. Golubovskaya VM, Gross S, Kaur AS et al (2003) Simultaneous inhibition of focal adhesion kinase and SRC enhances detachment and apoptosis in colon cancer cell lines. Mol Cancer Res 1:755-764
56. Kurenova E, Xu LH, Yang X et al (2004) Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein. Mol Cell Biol 24:4361-4371
57. Golubovskaya V, Beviglia L, Xu LH, Earp HS III, Craven R, Cance WG (2002) Dual inhibition of focal adhesion kinase and epidermal growth factor receptor pathways cooperatively induces death receptor-mediated apoptosis in human breast cancer cells. J Biol Chem 277:38978-38987
58. Hungerford JE, Compton MT, Matter ML, Hoffstrom BG, Otey CA (1996) Inhibition of pp125FAK in cultured fibroblasts results in apoptosis. J Cell Biol 135:1383-1390
59. Frisch SM, Vuori K, Ruoslahti E, Chan-Hui PY (1996) Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 134:793-799
60. Beviglia L, Golubovskaya V, Xu L, Yang X, Craven RJ, Cance WG (2003) Focal adhesion kinase N-terminus in breast carcinoma cells induces rounding, detachment and apoptosis. Biochem J 373:201-210
61. Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE (2004) Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: a novel therapeutic strategy in pancreatic cancer. Surgery 135:555-562
62. Miyazaki T, Kato H, Nakajima MH et al (2003) FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer 89:140-145
63. Mitra SK, Lim ST, Chi A, Schlaepfer DD (2006) Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model. Oncogene 25:4429-4440
64. Scibelli A, Tafuri S, Ferrante MC et al (2003) Ochratoxin A affects COS cell adhesion and signaling. Toxicol Appl Pharmacol 192:222-230
65. Reginato MJ, Mills KR, Paulus JK et al (2003) Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat Cell Biol 5:733-740
66. Zhang J, Zhi H, Zhou C et al (2005) Up-regulation of fibronectin in oesophageal squamous cell carcinoma is associated with activation of the Erk pathway. J Pathol 207:402-409
67. Mishima K, Inoue K, Hayashi Y (2002) Overexpression of extracellular-signal regulated kinases on oral squamous cell carcinoma. Oral Oncol 38:468-474
68. Schlaepfer DD, Hunter E (1997) Focal adhesion kinase overexpression enhances ras-dependent integrin signaling to ERK2/mitogen-activated protein kinase through interactions with and activation of c-Src. J Biol Chem 272:13189-13195
69. Renshaw MW, Price LS, Schwartz MA (1999) Focal adhesion kinase mediates the integrin signaling requirement for growth factor activation of MAP kinase. J Cell Biol 147:611-618
70. Zhang L, Bewick M, Lafrenie RM (2002) Role of Raf-1 and FAK in cell density-dependent regulation of integrin-dependent activation of MAP kinase. Carcinogenesis 23:1251-1258
71. Mitra SK, Mikolon D, Molina JE et al (2006) Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors. Oncogene 25:5969-5984
72. Zhou X, Murphy FR, Gehdu N, Zhang J, Iredale JP, Benyon RC (2004) Engagement of alphavbeta3 integrin regulates proliferation and apoptosis of hepatic stellate cells. J Biol Chem 279:23996-24006
73. Xue D-L, Meyers R, Homandberg GA (1992) Fibronectin fragments in osteoarthritic synovial fluid. J Rheumatol 19:1448-1452
74. Liu Y, Huang B, Yuan Y et al (2007) Inhibition of hepatocarcinoma and tumor metastasis to liver by gene therapy with recombinant CBD-HepII polypeptide of fibronectin. Int J Cancer 121:184-192
75. Birchler MT, Milisavlijevic D, Pfaltz M et al (2003) Expression of the extra domain B of fibronectin, a marker of angiogenesis, in head and neck tumors. Laryngoscope 113:1231-1237